QS-21
In stock
Description
Highly purified triterpenoid saponin molecules, consisting of a 35:65 mixture of QS-21-Xyl and QS-21-Api.
Proven Clinical Success: This product is approved for use in 5 human vaccines worldwide. It shows exceptional promise in the development of Oncology vaccines (e.g., Melanoma) and Infectious disease vaccines (e.g., HIV, Herpes Simplex, and Tuberculosis).
